Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 539

1.

Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.

Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I.

AIDS. 2004 Aug 20;18(12):1661-71.

PMID:
15280777
2.
3.

Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.

Rely K, Bertozzi SM, Avila-Figueroa C, Guijarro MT.

Health Policy Plan. 2003 Sep;18(3):290-8.

PMID:
12917270
4.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

5.
6.
7.

The value of contraception to prevent perinatal HIV transmission.

Reynolds HW, Janowitz B, Homan R, Johnson L.

Sex Transm Dis. 2006 Jun;33(6):350-6.

PMID:
16505747
9.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.

PMID:
10485721
10.

Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries.

Hashimoto H, Kapiga SH, Murata Y.

J Obstet Gynaecol Res. 2002 Dec;28(6):313-9.

PMID:
12512929
11.

Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.

Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA.

J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):369-77.

PMID:
11015154
12.

Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.

Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME.

Public Health Rep. 1996 Jul-Aug;111(4):335-41.

13.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
14.

Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania--a prospective cost-effectiveness study.

Robberstad B, Evjen-Olsen B.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):397-403. doi: 10.1097/QAI.0b013e3181eef4d3.

PMID:
20739897
15.

Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV.

Colvin M, Chopra M, Doherty T, Jackson D, Levin J, Willumsen J, Goga A, Moodley P; Good Start Study Group..

Bull World Health Organ. 2007 Jun;85(6):466-73.

17.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
18.

[The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].

Giraudon I, Leroy V, Msellati P, Elenga N, Ramon R, Welffens-Ekra C, Dabis F.

Sante. 1999 Sep-Oct;9(5):277-81. French.

19.
20.

Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.

Skordis J, Nattrass N.

J Health Econ. 2002 May;21(3):405-21. Erratum in: J Health Econ 2002 Sep;21(5):927.

PMID:
12022266

Supplemental Content

Support Center